Abstract: An easily wearable noninvasive living body measurement apparatus is provided. The noninvasive living body measurement apparatus (1) is composed of an apparatus body (3) and a wristband (40). The apparatus body (3) is composed of a body section (31) and a body section retention member (4). The body section (31) is retained by the wristband (40) via the body section retention member (4). By allowing the wristband (40) to be attached to a position in the vicinity of a wrist of a forearm of a human, the apparatus body (3) is attached to a human body. An imaging section (5) is retained at a position protruding outside from a width D of the wristband (40). This allows, when the wristband (40) is worn around the arm, the imaging section (5) to be located at a position at which the imaging by the imaging section (5) can be performed.

Abstract: The present invention is to present a noninvasive living body measuring device that is capable of simplifying the structure and performing the analysis with accuracy in a short time. The noninvasive living body measuring device comprises: a light source for illuminating a living body which includes a blood vessel; an imaging part for imaging the illuminated living body to obtain a living body image; and an analyzing part for obtaining a density of a component contained in blood of the living body based on an image of the blood vessel in the living body image, and correcting the density of the component based on an image of a peripheral tissue of the blood vessel in the living body image.

Abstract: A method of supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs is disclosed. The method provides a new value for judging an effect, a judgment score, which is calculated based on expression levels and activity values of two cyclin dependent kinases (CDKs). The effect of the treatment by using anthracycline anticancer drugs is judged by comparing the judgment score with a predetermined threshold level.

Abstract: A method of supporting a diagnosis of a risk of cancer recurrence is disclosed. The method provides a new determining value a recurrence risk score (RRS) which is calculated based on expression levels and activity values of two cyclin dependent kinases (CDKs). The risk of cancer recurrence is judged by comparing the RRS with a predetermined threshold level for RRS.

Abstract: A non-invasive living body measuring device is described, a representative one of which includes: a non-invasive living body measuring device for measuring the components contained in blood, comprising: an imaging part for imaging a living body; a display part; and a display control part for generating a blood vessel image showing blood vessels within a living body image obtained by the imaging part, and displaying the blood vessel image on the display part, wherein an index representing a suitable region for imaging by the imaging part is displayed on the display part.

Abstract: A cell analyzing apparatus, comprising: a parameter obtaining section for obtaining a characteristic parameter from a cell in a measurement sample; an imaging section for capturing an image of the cell in the measurement sample; an analyzing section for counting a cell in which the characteristic parameter meets a predetermined requirement among the cells in the measurement sample as a counting target and generating output data based on a counting result; a display section for displaying an image of the cell meeting the predetermined requirement and the output data; and an input section for receiving an instruction to specify the image displayed on the display section, wherein the analyzing section excludes a cell relevant to the specified image from the counting target and regenerates the output data is disclosed. A cell analyzing method is also disclosed.

Abstract: An easily wearable noninvasive living body measurement apparatus is provided. The noninvasive living body measurement apparatus (1) is composed of an apparatus body (3) and a wristband (40). The apparatus body (3) is composed of a body section (31) and a body section retention member (4). The body section (31) is retained by the wristband (40) via the body section retention member (4). By allowing the wristband (40) to be attached to a position in the vicinity of a wrist of a forearm of a human, the apparatus body (3) is attached to a human body. An imaging section (5) is retained at a position protruding outside from a width D of the wristband (40). This allows, when the wristband (40) is worn around the arm, the imaging section (5) to be located at a position at which the imaging by the imaging section (5) can be performed.

Abstract: A method of supporting a diagnosis of a risk of cancer recurrence is disclosed. The method provides a new determining value a recurrence risk score (RRS) which is calculated based on expression levels and activity values of two cyclin dependent kinases (CDKs). The risk of cancer recurrence is judged by comparing the RRS with a predetermined threshold level for RRS.

Abstract: A method of supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs is disclosed. The method provides a new value for judging an effect, a judgment score, which is calculated based on expression levels and activity values of two cyclin dependent kinases (CDKs). The effect of the treatment by using anthracycline anticancer drugs is judged by comparing the judgment score with a predetermined threshold level.

Abstract: A non-invasive blood component measuring device comprising: a light source section for irradiating a light to a blood vessel through a skin; an imaging section for imaging the irradiated blood vessel through the skin; and a controller, including a memory under control of a processor, the memory storing instructions enabling the processor to carry out operations, comprising: creating a concentration profile based on an image obtained by imaging the blood vessel with the imaging section; calculating a blood component concentration based on the concentration profile; acquiring a shape feature of the concentration profile; and correcting the blood component concentration based on the shape feature of the concentration profile is disclosed. A non-invasive blood component measuring method is also disclosed.

Abstract: The present invention is to present a noninvasive living body measuring device that is capable of simplifying the structure and performing the analysis with accuracy in a short time. The noninvasive living body measuring device comprises: a light source for illuminating a living body which includes a blood vessel; an imaging part for imaging the illuminated living body to obtain a living body image; and an analyzing part for obtaining a density of a component contained in blood of the living body based on an image of the blood vessel in the living body image, and correcting the density of the component based on an image of a peripheral tissue of the blood vessel in the living body image.

Abstract: A non-invasive living body measuring device is described, a representative one of which includes: a non-invasive living body measuring device for measuring the components contained in blood, comprising: an imaging part for imaging a living body; a display part; and a display control part for generating a blood vessel image showing blood vessels within a living body image obtained by the imaging part, and displaying the blood vessel image on the display part, wherein an index representing a suitable region for imaging by the imaging part is displayed on the display part.

Abstract: To provide a gene examination method for predicting the onset risk of glaucoma based on the relation between a glaucoma-associated gene and the onset of glaucoma, the onset of glaucoma in future is predicted by using as an indication mutations in the gene region involving the code region and/or the upstream region of a glaucoma-associated gene. In the base sequence represented by SEQ ID NO:1, mutation(s) in at least one of the following positions are detected, i.e., the 194-, 199-, 324-, 1051-, 1084-, 1627-, 1685-, 1756-, 1853-, 2830-, 3371-, 4037- and 4364-positions.

Abstract: A non-invasive living body measuring apparatus includes an image capturing section for capturing an image of the irradiated portion of the living body. When the image capturing section captures first and subsequent images of a portion of a living body at different times and the data processing section extracts characteristic patterns from the images, and sets an analysis region in the first image, the data processing section sets an analysis region in subsequent images based on a relative shift amount between the characteristic patterns of the first and subsequent image requisite for matching the characteristic patterns to each other.

Abstract: A method of displaying a scattergram includes measuring a plurality of particles with a particle measuring apparatus and preparing distribution data representing a frequency distribution of the particles on a two-dimensional coordinate plane based on a pair of parameters obtained from each of the particles. Thereafter, a scattergram is displayed based on the distribution data on a color display device by allowing the coordinates of a particle to correspond to a pixel, each of the pixels being made of three fundamental color luminescent components. A luminance of each of the three fundamental color luminescent components corresponds to a frequency of the particles on the scattergram. As such, the frequencies of the particles are displayed in different colors.